Back to top
more

Surmodics (SRDX)

(Delayed Data from NSDQ)

$38.20 USD

38.20
196,260

-0.17 (-0.44%)

Updated Oct 3, 2024 04:00 PM ET

After-Market: $38.21 +0.01 (0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 20% (49 out of 251)

Industry: Medical - Products

Better trading starts here.

Zacks News

Here's Why You Should Hold Integer Holdings in Your Portfolio

Integer Holdings' (ITGR) new strategy to drive sales and profit growth to provide the company with a competitive edge in the MedTech space.

    Merit Medical (MMSI) to Acquire Cianna Medical, Shares Up

    Merit Medical (MMSI) to leverage on Cianna Medical's SAVI and SCOUT platforms. The company plans to retain Cianna Medical's commercial and R&D teams after closure of the transaction.

      Omeros (OMER) Surges: Stock Moves 10.2% Higher

      Omeros (OMER) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.

        Baxter Collaborates With Mayo Clinic to Open Renal Care Center

        Per the agreement, Baxter (BAX) and Mayo Clinic researchers to form an outpatient clinic for kidney disease management, home dialysis and in-center dialysis services.

          Surmodics Sees Hammer Chart Pattern: Time to Buy?

          Surmodics has been struggling lately, but the selling pressure may be coming to an end soon.

            Is Surmodics (SRDX) Outperforming Other Medical Stocks This Year?

            Is (SRDX) Outperforming Other Medical Stocks This Year?

              Intuitive Surgical and InTouch Collaborate for IoMT Services

              Intuitive Surgical's (ISRG) IoMT likely to benefit patients; market prospects impressive.

                Sreyoshi Mukherjee headshot

                3 Top Stocks From the Booming US Medical Products Industry

                The U.S. Medical Products industry is sturdy on solid focus on technological advancement.

                  GW Pharmaceuticals (GWPH) Catches Eye: Stock Jumps 5.9%

                  GW Pharmaceuticals (GWPH) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

                    Medical - Products Stock Outlook: Short-Term Pain Inevitable

                    Near-term growth prospects of medical products are being questioned due to trade war apprehensions and President Trump's imposition of fresh tariffs on about $200 billion on Chinese imports.

                      Here's Why You Should Invest in Surmodics (SRDX) Stock Now

                      Continuous focus on R&D and a raised guidance for fiscal 2018 make Surmodics (SRDX) a lucrative pick for investors.

                        Baxter's Actifuse Flow Bone Graft Substitute Gets FDA Nod

                        The latest FDA approval for Baxter's (BAX) Actifuse Flow bone graft is likely to boost its Advanced Surgery segment.

                          Why Is SurModics (SRDX) Up 19.9% Since Last Earnings Report?

                          SurModics (SRDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                            Zacks.com highlights: Buckle, Illumina, Surmodics and Huntington Ingalls Industries

                            Zacks.com highlights: Buckle, Illumina, Surmodics and Huntington Ingalls Industries

                              Tirthankar Chakraborty headshot

                              4 of the Best Efficient Stocks to Enrich Your Portfolio

                              A company with a favorable efficiency level is expected to provide stellar returns as it is believed to be positively correlated with price performance.

                                Zacks.com highlights: Illumina, Vertex Pharmaceuticals, Surmodics and McDermott International

                                Zacks.com highlights: Illumina, Vertex Pharmaceuticals, Surmodics and McDermott International

                                  Tirthankar Chakraborty headshot

                                  4 Winning Stocks With Solid Efficiency Level

                                  A company with a favorable efficiency level is expected to provide stellar returns as it is believed to be positively correlated with price performance.

                                    Surmodics' (SRDX) IVD Unit Boosts Growth, R&D Focus Solid

                                    Surmodics' (SRDX) strong focus on R&D to provide it a competitive edge in the MedTech space.

                                      Surmodics (SRDX) Beats Q3 Earnings Estimates, Raises '18 View

                                      Surmodics' (SRDX) third-quarter fiscal 2018 results benefit from increase in royalty and license fee revenues.

                                        SurModics (SRDX) Tops Q3 Earnings and Revenue Estimates

                                        SurModics (SRDX) delivered earnings and revenue surprises of 437.50% and 12.20%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

                                          Sweta Killa headshot

                                          5 Top Performing Stocks of the Best ETF of 1H2018

                                          Inside the top performing stocks of the top ETF of the first half of 2018.

                                            Zacks.com featured highlights include: Illumina, Lululemon, Surmodics and ConocoPhillips

                                            Zacks.com featured highlights include: Illumina, Lululemon, Surmodics and ConocoPhillips

                                              Tirthankar Chakraborty headshot

                                              4 of the Best Efficient Stocks to Buy for Superb Returns

                                              We have considered four popular ratios in order to find efficient companies that have the potential to provide impressive returns

                                                Here's Why You Must Add Surmodics (SRDX) to Your Portfolio

                                                Surmodics' (SRDX) efforts to improve research and development stature bode well.

                                                  SYK or SRDX: Which is a Better Medical Product Stock?

                                                  Stryker (SYK) and Surmodics' (SRDX) strong fundamentals and rising share price make them close contenders.